Roth Capital Forecasts Nuwellis’ Q1 Earnings (NASDAQ:NUWE)

Nuwellis, Inc. (NASDAQ:NUWEFree Report) – Investment analysts at Roth Capital decreased their Q1 2025 earnings per share estimates for Nuwellis in a report issued on Tuesday, March 11th. Roth Capital analyst J. Aschoff now forecasts that the company will earn ($0.45) per share for the quarter, down from their previous estimate of ($0.30). The consensus estimate for Nuwellis’ current full-year earnings is ($8.17) per share. Roth Capital also issued estimates for Nuwellis’ Q2 2025 earnings at ($0.36) EPS, Q3 2025 earnings at ($0.35) EPS, Q4 2025 earnings at ($0.28) EPS, FY2025 earnings at ($1.39) EPS, FY2026 earnings at ($0.52) EPS, FY2027 earnings at $0.09 EPS, FY2028 earnings at $0.78 EPS and FY2029 earnings at $1.41 EPS.

Nuwellis Stock Performance

Shares of NUWE stock opened at $1.18 on Thursday. The stock’s fifty day moving average is $1.22 and its 200-day moving average is $1.34. The stock has a market capitalization of $5.16 million, a PE ratio of -0.01 and a beta of 0.36. Nuwellis has a 52 week low of $0.92 and a 52 week high of $17.15.

Hedge Funds Weigh In On Nuwellis

A hedge fund recently bought a new stake in Nuwellis stock. Geode Capital Management LLC purchased a new stake in Nuwellis, Inc. (NASDAQ:NUWEFree Report) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 30,806 shares of the company’s stock, valued at approximately $34,000. Geode Capital Management LLC owned about 0.70% of Nuwellis as of its most recent SEC filing. Institutional investors and hedge funds own 3.13% of the company’s stock.

About Nuwellis

(Get Free Report)

Nuwellis, Inc, a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter.

Further Reading

Earnings History and Estimates for Nuwellis (NASDAQ:NUWE)

Receive News & Ratings for Nuwellis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nuwellis and related companies with MarketBeat.com's FREE daily email newsletter.